Biotech

All Articles

Lilly- supported effective weight loss biotech reports IPO

.After raising $170 thousand back in February, metabolic disease-focused BioAge Labs has actually fi...

Aelis' cannabis make use of medicine flunks phase 2b, steering Indivior to re-think $100M alternative

.Aelis Farma's hopes of securing an easy, positive selection on a $100 thousand option repayment hav...

ProKidney halts stage 3 trial not needed to have for cell therapy approval

.ProKidney has quit one of a set of period 3 trials for its cell treatment for kidney condition afte...

Vaxcyte surges on 'spectacular' 31-valent PCV gain versus Pfizer

.Vaxcyte unveiled what analysts referred to as "spectacular" phase 1/2 data for its 31-valent pneumo...

Recursion's mind health condition trial reveals scant evidence of efficiency

.Recursion has actually stumbled with an early examination of its own tech-enabled approach to medic...

Acepodia, Pfizer click all together for chemistry-based tissue therapy

.Contact it a case of great chemistry: Acepodia, a biotech based on Nobel Prize-winning science, is ...

Praxis epilepsy medicine decreases seizures in period 2 trial

.Praxis Precision Medicines has scored an additional midphase gain in epilepsy this year, with its o...

Three execs resign as Dyne articles combined data for DMD candidate

.After getting away a medical hold a number of years back, Dyne Therapy has shown new phase 1/2 info...

Arrowhead fires off phase 3 information in rare metabolic disease in advance of market clash with Ionis

.Arrowhead Pharmaceuticals has actually revealed its own hand before a potential showdown with Ionis...

Pfizer, Valneva show lyme illness chance successful for 2nd enhancer

.Pfizer and also Valneva may have regarding 2 additional years to stand by before they produce the i...